Department of Geriatric and Palliative Medicine, Tropenklinik Paul-Lechler-Krankenhaus, Tübingen, Germany.
Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany.
PLoS One. 2022 Jul 29;17(7):e0271822. doi: 10.1371/journal.pone.0271822. eCollection 2022.
COVID-19 is a severe disease with a high need for intensive care treatment and a high mortality rate in hospitalized patients. The objective of this study was to describe and compare the clinical characteristics and the management of patients dying with SARS-CoV-2 infection in the acute medical and intensive care setting.
Descriptive analysis of dying patients enrolled in the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS), a non-interventional cohort study, between March 18 and November 18, 2020. Symptoms, comorbidities and management of patients, including palliative care involvement, were compared between general ward and intensive care unit (ICU) by univariate analysis.
580/4310 (13%) SARS-CoV-2 infected patients died. Among 580 patients 67% were treated on ICU and 33% on a general ward. The spectrum of comorbidities and symptoms was broad with more comorbidities (≥ four comorbidities: 52% versus 25%) and a higher age distribution (>65 years: 98% versus 70%) in patients on the general ward. 69% of patients were in an at least complicated phase at diagnosis of the SARS-CoV-2 infection with a higher proportion of patients in a critical phase or dying the day of diagnosis treated on ICU (36% versus 11%). While most patients admitted to ICU came from home (71%), patients treated on the general ward came likewise from home and nursing home (44% respectively) and were more frequently on palliative care before admission (29% versus 7%). A palliative care team was involved in dying patients in 15%. Personal contacts were limited but more often documented in patients treated on ICU (68% versus 47%).
Patients dying with SARS-CoV-2 infection suffer from high symptom burden and often deteriorate early with a demand for ICU treatment. Therefor a demand for palliative care expertise with early involvement seems to exist.
COVID-19 是一种严重疾病,住院患者需要重症监护治疗,死亡率高。本研究的目的是描述和比较在急性内科和重症监护环境中死于 SARS-CoV-2 感染的患者的临床特征和管理。
对 2020 年 3 月 18 日至 11 月 18 日期间参加非干预性队列研究 LEOSS(Lean European Open Survey on SARS-CoV-2 Infected Patients)的死亡患者进行描述性分析。通过单变量分析比较普通病房和重症监护病房(ICU)患者的症状、合并症和管理情况,包括姑息治疗的参与情况。
4310 例 SARS-CoV-2 感染患者中 580 例死亡。580 例患者中,67%在 ICU 治疗,33%在普通病房治疗。合并症和症状谱广泛,普通病房患者合并症更多(≥ 4 种合并症:52%比 25%),年龄分布更高(>65 岁:98%比 70%)。69%的患者在 SARS-CoV-2 感染诊断时至少处于复杂阶段,更多处于危急阶段或在诊断当天死亡的患者在 ICU 治疗(36%比 11%)。虽然大多数 ICU 收治的患者来自家中(71%),但普通病房收治的患者同样来自家中和养老院(分别为 44%),入院前更常接受姑息治疗(29%比 7%)。15%的死亡患者有姑息治疗团队参与。人际接触虽有限,但 ICU 治疗患者记录更多(68%比 47%)。
死于 SARS-CoV-2 感染的患者承受着高症状负担,病情常常早期恶化,需要 ICU 治疗。因此,似乎需要姑息治疗专业人员的早期介入。